165 related articles for article (PubMed ID: 21296329)
1. Risk factors for the development and progression of carcinoid heart disease.
Bhattacharyya S; Toumpanakis C; Chilkunda D; Caplin ME; Davar J
Am J Cardiol; 2011 Apr; 107(8):1221-6. PubMed ID: 21296329
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with progression of carcinoid heart disease.
Møller JE; Connolly HM; Rubin J; Seward JB; Modesto K; Pellikka PA
N Engl J Med; 2003 Mar; 348(11):1005-15. PubMed ID: 12637610
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.
Denney WD; Kemp WE; Anthony LB; Oates JA; Byrd BF
J Am Coll Cardiol; 1998 Oct; 32(4):1017-22. PubMed ID: 9768727
[TBL] [Abstract][Full Text] [Related]
4. Echocardiographic follow-up of treated patients with carcinoid syndrome.
Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
[TBL] [Abstract][Full Text] [Related]
5. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
[TBL] [Abstract][Full Text] [Related]
6. Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.
Dobson R; Burgess MI; Valle JW; Pritchard DM; Vora J; Wong C; Chadwick C; Keevi B; Adaway J; Hofmann U; Poston GJ; Cuthbertson DJ
Br J Cancer; 2014 Oct; 111(9):1703-9. PubMed ID: 25211656
[TBL] [Abstract][Full Text] [Related]
7. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S
Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular abnormalities in patients with a carcinoid syndrome.
Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
[TBL] [Abstract][Full Text] [Related]
9. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, one-year-incidence and predictors of carcinoid heart disease.
Mattig I; Franke MR; Pschowski R; Brand A; Stangl K; Knebel F; Dreger H
Cardiovasc Ultrasound; 2023 Sep; 21(1):18. PubMed ID: 37752548
[TBL] [Abstract][Full Text] [Related]
11. Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland.
Dobson R; Valle JW; Burgess MI; Poston GJ; Cuthbertson DJ
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):741-6. PubMed ID: 26170123
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.
Mansencal N; McKenna WJ; Mitry E; Beauchet A; Pellerin D; Rougier P; Dubourg O
Am J Cardiol; 2010 Feb; 105(4):527-31. PubMed ID: 20152249
[TBL] [Abstract][Full Text] [Related]
13. The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
Dobson R; Burgess MI; Banks M; Pritchard DM; Vora J; Valle JW; Wong C; Chadwick C; George K; Keevil B; Adaway J; Ardill JE; Anthoney A; Hofmann U; Poston GJ; Cuthbertson DJ
PLoS One; 2013; 8(9):e73679. PubMed ID: 24069222
[TBL] [Abstract][Full Text] [Related]
14. Carcinoid heart disease: Diagnosis and management.
Luis SA; Pellikka PA
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):149-58. PubMed ID: 26971851
[TBL] [Abstract][Full Text] [Related]
15. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.
Robiolio PA; Rigolin VH; Wilson JS; Harrison JK; Sanders LL; Bashore TM; Feldman JM
Circulation; 1995 Aug; 92(4):790-5. PubMed ID: 7641358
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in diagnosis and perioperative management of carcinoid heart disease.
Castillo JG; Silvay G; Solís J
Semin Cardiothorac Vasc Anesth; 2013 Sep; 17(3):212-23. PubMed ID: 23171718
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid heart disease.
Bernheim AM; Connolly HM; Hobday TJ; Abel MD; Pellikka PA
Prog Cardiovasc Dis; 2007; 49(6):439-51. PubMed ID: 17498524
[TBL] [Abstract][Full Text] [Related]
19. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.
Himelman RB; Schiller NB
Am J Cardiol; 1989 Feb; 63(5):347-52. PubMed ID: 2464278
[TBL] [Abstract][Full Text] [Related]
20. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
